News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

Navigating the Confluence of Respiratory Pathogens: Preparing for the Winter Triple Threat

September 30, 2023
By Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC
News
Article

Medical investigators are concerned about a triple threat this winter with COVID-19, influenza, and RSV. Vaccination is crucial, but distribution challenges remain. Wearing masks, hand hygiene, and ventilation is important to prevent infections. Hospitals need comprehensive plans to respond efficiently.

Triple virus outbreak or Tripledemic: Covid-19, influenza, and  respiratory syncytial virus (RSV)    (© Adobe Stock, 55600564 by freshidea)

Triple virus outbreak or Tripledemic: Covid-19, influenza, and respiratory syncytial virus (RSV)

(© Adobe Stock, 55600564 by freshidea)

The concern of a tripledemic isn’t new to the 2023-2024 winter season. We’ve been worried about it since the COVID-19 pandemic started, with concern escalating in 2021 (and since then) as people became less concerned about respiratory viruses and were desperate to get out of the stay-at-home/wear-a-mask time. Now, though, we’re entering a new phase of this COVID-19 world, the post-emergency state of COVID-19, in which things have mostly gone back to normal, and we’re navigating sustained response to a pathogen that isn’t so novel. Our concern—and rightfully so—is if we’ll see a tripledemic. Three surges of respiratory pathogens during the winter, all converging on us at the same time, requiring public health and health care to manage response against COVID-19, influenza, and respiratory syncytial virus (RSV). A convergence of respiratory pathogens upon a burnt-out, fatigued, and increasingly stressed workforce during a time when we’re struggling to stop the cycle of panic and neglect and ensure sustainable resources and support for public health and pandemic preparedness.

Predictions in this case are difficult, though, because there are indications that we’ll see some surge, but hopefully, not as bad as predicted. So far, COVID-19 seems to be trending down. Hospitalizations are down in the United States, as well as emergency room visits (down 19.3%), according to data reported by the CDC. In week 38 of influenza tracking, the CDC hasn’t seen drastic increases. Looking back to week 40 of the 2022-2023 season, we already saw an uptick. That means that we’re not seeing the swift rise in numbers that would point to an early influenza season. Peaks are usually around weeks 48 and 50, so the next 2 months will be telling. Of the 42,904 specimens tested this week, 0.9% were positive, and a majority were influenza A. Looking a week back, that’s a bit of an increase, as test positivity was 0.8%. Looking back to the 2021-2022 influenza season for week 38, the CDC reported 50,292 specimens tested, with a positivity of 1.3% and much higher rates of influenza A.

Also in the Tripledemic Fall/Winter 2023-2024 Article Series

  • Low Vaccination Concerns Highlight Need for Fall and Winter 2023 Vaccination Campaigns
  • Evolving Symptomatology: Respiratory Viruses in the Era of COVID-19 Variants
  • How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

What about RSV and Influenza?

If we shift our attention to RSV, the latest data does show an uptick in RSV detection via PCR and antigen tests. These increases are concerning, and while not steep rises in cases, they may be the first indicators of a rough season coming our way. In addition to pathogen-specific surveillance, syndromic surveillance is helpful because we can see trends based on symptoms and preliminary diagnostics.

Utilizing the Influenza-like Illness Surveillance Network (ILINet), there has been an increase in outpatient respiratory illness visits, with 2.0% of reported patients experiencing symptoms like fever, sore throat, cough, etc. This season, we’re seeing an earlier rise in cases (compared to pre-COVID-19 seasons). Still, given that it is symptom-specific, it reflects symptoms that could indicate COVID-19, RSV, influenza, and other respiratory viruses. In short, we are seeing an uptick in respiratory viruses—specifically RSV and influenza, and a bit of a decline in cases of COVID-19. This can make for somewhat of a confusing time. If there’s one thing we’ve learned over the years, it’s that too often, respiratory virus season doesn’t play its hand too early. The 2017-2018 influenza season was particularly rough, and it wasn’t until weeks 42 and 43 that we started to see that rapid climb in cases, and week 49 was the indication of things to come. We will, of course, see an increase in cases—that is what history has taught us—but the severity of it and our capacity to respond in both the care of patients and prevention of additional cases depends on what we do now.

Avoiding--or At Least Curbing--the Tripledemic

First: vaccination. We are in one of the best positions in history to address these pathogens with vaccines. A new COVID-19 booster, an annually-updated influenza shot, and for the first time, new strategies to tackle RSV—an RSV vaccine approved for older adults, and an antibody treatment, Beyfortus, to protect infants, and a maternal vaccine to protect pregnant individuals and young infants. The issue now is to ensure people get the shots but also have easy access, which has been a challenge with reported hurdles due to insurance, supplies, and cost. Less than 20% of Americans got the previous COVID-19 booster, which doesn’t bode well for this season. Reports of a less-than-ideal booster rollout aren’t helping either.

“And the vaccine manufacturers say they've got sufficient doses available—the problem seems to be with distribution, [Jennifer Kates, senior vice president and director of the Global Health & HIV Policy Program at the Kaiser Family Foundation] explains [to National Public Radio]. Unlike years past when the federal government purchased the vaccines and made them free to consumers, this year, pharmacies had to buy the vaccines from suppliers. ‘This is the first time that the vaccines are being commercialized. They're being largely procured, supplied, [and] paid for in the private sector. So, it's sort of our health care system as we know it,’ Kates says. The problems include issues with insurance coverage. Since the government is no longer giving the shots away for free, most people need to use their health insurance to pay for them. (The federal government is only making the vaccines free for the uninsured, via a temporary program called Bridge Access.)”

What Else Can We do?

In addition to vaccines, we have the usual host of respiratory virus prevention strategies—staying home when sick, masking, hand hygiene, cleaning and disinfection, testing, and improving ventilation. For infection prevention programs, though, facing an impending tripledemic, no matter how severe it gets, requires us to prepare in a way that is a bit novel. Over the past few years, COVID-19 has translated to visitor restrictions, widespread masking, and prevention strategies covering the non-COVID-19 respiratory viruses we’re discussing. We are moving to a sustainable approach to COVID-19 prevention, including it as another respiratory pathogen we must prepare and respond to rather than the emergent and novel pathogen. This requires infection control and prevention programs to integrate COVID-19 metrics into respiratory virus season strategies, such as looking at these 3 viruses to establish metrics for actions, like visitor restrictions, universal or targeted masking (if not already in place), and enhanced measures to combat the growing cases we’re seeing in the community. Determining these now and, importantly, working with leadership and health care workers to ensure education and communication will be vital. Without federal- and state-based guidance, we’re in somewhat uncharted territory where variations between facilities will become increasingly apparent.

The truth is that right now, the data is showing indications of rising influenza and RSV cases, whereas winter COVID-19 surges tend to start in late October and early November. It will likely be a few weeks until we begin to see how steep the rise is and how severe a tripledemic is—if it happens. Regardless, we can determine just how bad it is. For IPC programs, taking the lessons of past winters and COVID-19 surges, we can build integrated plans that are agile and targeted. I’m hopeful that in 6 months, when we look back at this season, we’ll see a curbed respiratory virus season, made mild by our actions rather than severe by inaction and indifference.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe Now!
Recent Videos
DJ Shannon, MPH, CIC, VA-BC, FAPIC
Jordan Bastian, MPH, CIC, at APIC25
Jordan Bastian, MPH, CIC, at APIC25
Rebecca Battjes, MPH, CIC, FAPIC; Vidya Nankoosingh, MLT, CIC; and Peter Teska, MBA
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Matthias Tschoerner, Dr Sc
Related Content

Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported

Tori Whitacre Martonicz
July 18th 2025
Article

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.


Realistic electron microscopy of Clostridioides difficile, highly detailed rod-shaped structure, spores with textured surfaces, flagella, acid-green and purple hues, contrasting black background.  (Adobe Stock 1318793046 by Waseem by AI)

New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain

Tori Whitacre Martonicz
July 17th 2025
Article

A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.


What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

Tori Whitacre Martonicz
July 16th 2025
Article

Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.


Operating room, surgical site infections   (Adobe Stock, Unknown)

The Next Frontier in Infection Control: AI-Driven Operating Rooms

Tori Whitacre Martonicz
Published: July 15th 2025 | Updated: July 15th 2025
Article

Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.


The doctor is injecting a vaccination into the arm of a little girl.   Adobe Stock 170524806 by pingpao

Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence

Tori Whitacre Martonicz
July 15th 2025
Article

New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.


The doctor is injecting a vaccination into the arm of a little girl.   Adobe Stock 170524806 by pingpao

No Link Found Between Aluminum in Vaccines and Chronic Disorders

Tori Whitacre Martonicz
July 14th 2025
Article

A Danish study of 1.2 million children found no increased risk of autoimmune, allergic, or neurodevelopmental disorders from aluminum in early childhood vaccines, helping close key safety evidence gaps.

Related Content

Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported

Tori Whitacre Martonicz
July 18th 2025
Article

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.


Realistic electron microscopy of Clostridioides difficile, highly detailed rod-shaped structure, spores with textured surfaces, flagella, acid-green and purple hues, contrasting black background.  (Adobe Stock 1318793046 by Waseem by AI)

New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain

Tori Whitacre Martonicz
July 17th 2025
Article

A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.


What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness

Tori Whitacre Martonicz
July 16th 2025
Article

Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.


Operating room, surgical site infections   (Adobe Stock, Unknown)

The Next Frontier in Infection Control: AI-Driven Operating Rooms

Tori Whitacre Martonicz
Published: July 15th 2025 | Updated: July 15th 2025
Article

Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.


The doctor is injecting a vaccination into the arm of a little girl.   Adobe Stock 170524806 by pingpao

Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence

Tori Whitacre Martonicz
July 15th 2025
Article

New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.


The doctor is injecting a vaccination into the arm of a little girl.   Adobe Stock 170524806 by pingpao

No Link Found Between Aluminum in Vaccines and Chronic Disorders

Tori Whitacre Martonicz
July 14th 2025
Article

A Danish study of 1.2 million children found no increased risk of autoimmune, allergic, or neurodevelopmental disorders from aluminum in early childhood vaccines, helping close key safety evidence gaps.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News